Ahmad Abbadi

Ahmad Abbadi

Auto-generated profile, based on publicly available information

Ahmad Abbadi

Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Solna, Sweden

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2023 in Research Synthesis Methods
Verified
Journal Article
Open access
MKMariam Kirvalidze
Mariam Kirvalidze
AAAhmad Abbadi
Ahmad Abbadi
LDLena Dahlberg
Lena Dahlberg
LSLawrence B. Sacco
Lawrence B. Sacco
ACAmaia Calderón-Larrañaga
Amaia Calderón-Larrañaga
LMLucas Morin
Lucas Morin
Umbrella reviews (reviews of systematic reviews) are increasingly used to synthesize findings from systematic reviews. One important challenge when pooling data from several systematic reviews is publication overlap, that is, the same primary publications being included in multiple reviews. Pieper et al. have proposed using the corrected covered area (CCA) index to quantify the degree of overlap between systematic reviews to be pooled in an umbrella review. Recently, this methodology has been integrated in Excel‐ or R‐based tools for easier use. In this short letter, we highlight an important consideration for using the CCA methodology for pairwise overlap assessment, especially when reviews include varying numbers of primary publications, and we urge researchers to fine‐tune this method and exercise caution when review exclusion decisions are based on its output.

21 April 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
MKMariam Kirvalidze
Mariam Kirvalidze
AAAhmad Abbadi
Ahmad Abbadi
LDLena Dahlberg
Lena Dahlberg
LSLawrence B Sacco
Lawrence B Sacco
LMLucas Morin
Lucas Morin
ACAmaia Calderón-Larrañaga
Amaia Calderón-Larrañaga
Objectives This umbrella review aimed to evaluate whether certain interventions can mitigate the negative health consequences of caregiving, which interventions are more effective than others depending on the circumstances, and how these interventions are experienced by caregivers themselves. Design An umbrella review of systematic reviews was conducted. Data sources Quantitative (with or without meta-analyses), qualitative and mixed-methods systematic reviews were included. Eligibility criteria Reviews were considered eligible if they met the following criteria: included primary studies targeting informal (ie, unpaid) caregivers of older people or persons presenting with ageing-related diseases; focused on support interventions and assessed their effectiveness (quantitative reviews) or their implementation and/or lived experience of the target population (qualitative reviews); included physical or mental health-related outcomes of informal caregivers. Data extraction and synthesis A total of 47 reviews were included, covering 619 distinct primary studies. Each potentially eligible review underwent critical appraisal and citation overlap assessment. Data were extracted independently by two reviewers and cross-checked. Quantitative review results were synthesised narratively and presented in tabular format, while qualitative findings were compiled using the mega-aggregation framework synthesis method. Results The evidence regarding the effectiveness of interventions on physical and mental health outcomes was inconclusive. Quantitative reviews were highly discordant, whereas qualitative reviews only reported practical, emotional and relational benefits. Multicomponent and person-centred interventions seemed to yield highest effectiveness and acceptability. Heterogeneity among caregivers, care receivers and care contexts was often overlooked. Important issues related to the low quality of evidence and futile overproduction of similar reviews were identified. Conclusions Lack of robust evidence calls for better intervention research and evaluation practices. It may be warranted to avoid one-size-fits-all approaches to intervention design. Primary care and other existing resources should be leveraged to support interventions, possibly with increasing contributions from the non-profit sector. PROSPERO registration number CRD42021252841; BMJ Open: doi:10.1136/bmjopen-2021-053117.

30 January 2024 in Journal of Multimorbidity and Comorbidity
Verified
Journal Article
Open access
GBGiorgi Beridze
Giorgi Beridze
AAAhmad Abbadi
Ahmad Abbadi
JAJoan Ars
Joan Ars
FRFrancesca Remelli
Francesca Remelli
DVDavide Liborio Vetrano
Davide Liborio Vetrano
ACAmaia Calderón-Larrañaga
Amaia Calderón-Larrañaga
Background: Multimorbidity, the coexistence of multiple chronic conditions in an individual, is a complex phenomenon that is highly prevalent in primary care settings, particularly in older individuals. This systematic review summarises the current evidence on multimorbidity patterns identified in primary care electronic health record (EHR) data. Methods: Three databases were searched from inception to April 2022 to identify studies that derived original multimorbidity patterns from primary care EHR data. The quality of the included studies was assessed using a modified version of the Newcastle-Ottawa Quality Assessment Scale. Results: Sixteen studies were included in this systematic review, none of which was of low quality. Most studies were conducted in Spain, and only one study was conducted outside of Europe. The prevalence of multimorbidity (i.e. two or more conditions) ranged from 14.0% to 93.9%. The most common stratification variable in disease clustering models was sex, followed by age and calendar year. Despite significant heterogeneity in clustering methods and disease classification tools, consistent patterns of multimorbidity emerged. Mental health and cardiovascular patterns were identified in all studies, often in combination with diseases of other organ systems (e.g. neurological, endocrine). Discussion: These findings emphasise the frequent coexistence of physical and mental health conditions in primary care, and provide useful information for the development of targeted preventive and management strategies. Future research should explore mechanisms underlying multimorbidity patterns, prioritise methodological harmonisation to facilitate the comparability of findings, and promote the use of EHR data globally to enhance our understanding of multimorbidity in more diverse populations.

6 November 2020 in Journal of Environmental and Public Health
Verified
Journal Article
Open access
PDF file
AAAhmad Abbadi
Ahmad Abbadi
JAJawad Alnahar
Jawad Alnahar
SZSohaib Zoghoul
Sohaib Zoghoul
ABAbdullah Bsoul
Abdullah Bsoul
Salameh Abdalmajeed AlaroodSalameh Abdalmajeed Alarood
Salameh Abdalmajeed Alarood
SASukaina Alzyoud
Sukaina Alzyoud
Background. Waterpipe nicotine dependence and its association with depressive symptoms and dual usage among adolescents are currently not examined in the literature. Adolescents are a vulnerable population that is susceptible to depression and initiation of tobacco use. We aim, in this novel study, to assess the association between depressive symptoms and waterpipe nicotine dependence among adolescents in Jordan, evaluate the association between waterpipe smoking status (waterpipe smoker vs. dual user) and waterpipe nicotine dependence, and assess the internal validity of the Waterpipe Nicotine Dependence Scale (WNDS). Method. A cross-sectional study among adolescents of grade 9th to 12th in Jordan was conducted through multistage cluster random sampling. The self-reported Arabic Youth Tobacco Use Composite Measure Questionnaire (YTUCM) was used to collect the surveys that include demographic information, smoking status, and the WNDS to assess waterpipe nicotine dependence and depressive symptoms. Multiple linear regression and the t-test were used to analyze the data. Findings. One thousand three hundred and three surveys were collected, of which 1082 were included in the study (443 males and 639 females). 64.9 of the sample were nontobacco users, while 20.1 were waterpipe- (WTP-) only smokers, 11.4 were dual users, and 3.7 were cigarettes-only users. After adjusting for weights, 66.6 were nonsmokers, 19.2 were WTP-only smokers, 10.2 were dual users, and 3.9 were cigarettes-only smokers. Using multiple linear regression, depressive symptoms were significantly associated with WTP nicotine dependence (β 0.618), upon adjusting for confounders. Furthermore, dual users were associated with higher WTP nicotine dependence (β 12.034) compared to WTP-only smokers after adjusting for confounders. Cronbachs alpha for the WNDS was 0.955. Conclusions. Our study shows that there is a statistically significant association between depressive symptoms and WTP nicotine dependence and higher dependence among dual users compared to WTP-only smokers. The WNDS can be a useful tool to assess WTP nicotine dependence with high internal consistency. However, a longitudinal study is needed to further understand the association and temporality between the depressive symptoms and WTP nicotine dependence. Additionally, research is needed to shorten the WNDS while maintaining high internal consistency and assess the external validity of the WNDS and the short- and long-term consequences of dual usage.

6 April 2025 in eClinicalMedicine
Verified
Journal Article
Open access
AAAhmad Abbadi
Ahmad Abbadi
MEMartin Eklund
Martin Eklund
ALAnna Lantz
Anna Lantz
ADAndrea Discacciati
Andrea Discacciati
LBLars Björnebo
Lars Björnebo
TNTobias Nordström
Tobias Nordström
Indeterminate lesions on prostate MRI, such as PI-RADS 3, present a clinical challenge due to their equivocal nature, complicating biopsy decisions in men undergoing testing for prostate cancer. Understanding the predictive capacity of biomarkers and risk calculators is critical to improve clinical decision-making and reduce unnecessary biopsies. In this prospective cohort study, men with PI-RADS 3 findings on biparametric MRI (bp-MRI) who underwent combined biopsy (fusion targeted and systematic) in the STHLM3-MRI randomised clinical trial (first- and second-rounds) and at Capio St Göran's Hospital (Capio PCC), Sweden were included, representing screening-by-invitation, repeat screening, and clinical practice cohorts, respectively. Data collection occurred between Feb 5th, 2018, and Mar 4th, 2020, for STHLM3-MRI first-round screening, between Nov 10th, 2021, and Feb 20th, 2023 for second-round screening, and between Jan 7th, 2017 and June 30th, 2023 for Capio PCC. The data was collected directly from the participating laboratories using standardized reporting forms, medical charts, and additional study-specific data collection forms filled by patients. The primary outcome was detection of clinically significant prostate cancer (csPCa; ISUP ≥2) in men with PSA ≥3 ng/mL confirmed by the combined biopsy. The predictive capacity of the evaluated biomarkers (PSA density, the Stockholm3 test, prostate volume, MRI lesion volume ratio, and Stockholm3 density), as well as seven risk calculators, was assessed via the area under the curve (AUC) computed using logistic regression. Sensitivity and specificity of detecting csPCa and high-grade prostate cancer (ISUP ≥3) were reported. Complete-case analysis was performed for men with complete data on their PSA, prostate volume, Stockholm3 test, MRI lesion volume, findings on the digital rectal examination, family history of prostate cancer, and previous biopsy. The findings were contrasted to the analysis from the imputed dataset. Of the 6554 men included into the three cohorts, 1187 received PI-RADS score of 3 on the bp-MRI, and 1146 underwent combined biopsy. Of them, 900 had PSA ≥3 ng/mL, and 656 men were included in the complete-case analysis (169 from STHLM3-MRI first-round, 72 from the second-round, and 415 from Capio PCC). Overall, 370/900 men (41%) and 258/656 men (39%) had ISUP ≥2, but only 75/900 (8%) and 50/656 (8%) had ISUP ≥3. PSA density, tested risk calculators, and probability tests had low-to-moderate AUC (range 0.50–0.73; PSA density range 0.58–0.66, Stockholm3 range 0.59–0.67, lesion volume ratio range 0.54–0.63), and performed similarly across individual cohorts and the combined dataset in the complete-case and imputed dataset analysis. For detection of ISUP ≥2 based on STHLM3-MRI first-round, PSA density at 0.10 had a sensitivity of 69% (56%, 80%), specificity of 49% (39%, 58%), and missing 27% (6%, 61%) of ISUP ≥3, while a PSA density of 0.15 had a sensitivity of 37% (25%, 50%), specificity of 84% (76%, 90%), missing 45% (17%, 70%) of ISUP ≥3. The best-performing model based on STHLM3-MRI included age, prostate volume, Stockholm3 density and MRI lesion ratio, and reduced prostate biopsies by 33% (26%, 40%) while maintaining 98% (91%, 100%) sensitivity to detect ISUP ≥2 cancer, specificity of 50% (41%, 60%) and AUC of 0.82 (0.76, 0.87). Meanwhile, the best-performing model based on the complete-case combined dataset included age, prostate volume, PSA density, and Stockholm3 density, and reduce prostate biopsies by 26% (23%, 30%) with a sensitivity of 90% (85%, 93%), specificity of 36% (31%, 41%), and AUC of 0.70 (0.66, 0.74). Current risk-stratification tools and individual biomarkers perform suboptimally for guiding biopsy decisions in men with PI-RADS 3 lesions. The findings highlight the limitations of relying on PSA density alone and emphasize the need for caution in clinical recommendations. However, multiplex models might offer possibility to reduce unnecessary biopsies while maintaining high sensitivity for clinically significant prostate cancer detection. These findings should be externally validated and evaluated for cost-effectiveness. STHLM3-MRI clinical trial is funded by the 10.13039/501100002794 Swedish Cancer Society (Cancerfonden), the 10.13039/501100004359 Swedish Research Council (Vetenskapsrådet), the 10.13039/501100004359 Swedish Research Council for Health Working Life and Welfare (FORTE), the Strategic Research Programme on Cancer (StratCan), Hagstrandska Minnesfonden, Region Stockholm, Svenska Druidorden, Åke Wibergs Stiftelse, the 10.13039/100017156 Swedish e-Science Research Centre , the 10.13039/501100004047 Karolinska Institutet , and Prostatacancerförbundet.

10 June 2024 in BMC Medicine
Verified
Journal Article
Open access
PDF file
AAAhmad Abbadi
Ahmad Abbadi
EKEmmanouil Kokoroskos
Emmanouil Kokoroskos
MSMatthew Stamets
Matthew Stamets
DVDavide Liborio Vetrano
Davide Liborio Vetrano
NONicola Orsini
Nicola Orsini
ACAmaia Calderón-Larrañaga
Amaia Calderón-Larrañaga
Background: As global aging accelerates, routinely assessing the functional status and morbidity burden of older patients becomes paramount. The aim of this study is to assess the validity of the comprehensive clinical and functional Health Assessment Tool (HAT) based on four cohorts of older adults (60 + years) from the Swedish National study on Aging and Care (SNAC) spanning urban, suburban, and rural areas. Methods: The HAT integrates five health indicators (gait speed, global cognition, number of chronic diseases, and basic and instrumental activities of daily living), providing an individual-level score between 0 and 10. The tool was constructed using nominal response models, first separately for each cohort and then in a harmonized dataset. Outcomes included all-cause mortality over a maximum follow-up of 16 years and unplanned hospital admissions over a maximum of 3 years of follow-up. The predictive capacity was assessed through the area under the curve (AUC) using logistic regressions. For time to death, Cox regressions were performed, and Harrell’s C-indices were reported. Results from the four cohorts were pooled using individual participant data meta-analysis and compared with those from the harmonized dataset. Results: The HAT demonstrated high predictive capacity across all cohorts as well as in the harmonized dataset. In the harmonized dataset, the AUC was 0.84 (95% CI 0.81–0.87) for 1-year mortality, 0.81 (95% CI 0.80–0.83) for 3-year mortality, 0.80 (95% CI 0.79–0.82) for 5-year mortality, 0.69 (95% CI 0.67–0.70) for 1-year unplanned admissions, and 0.69 (95% CI 0.68–0.70) for 3-year unplanned admissions. The Harrell’s C for time-to-death throughout 16 years of follow-up was 0.75 (95% CI 0.74–0.75). Conclusions: The HAT is a highly predictive, clinically intuitive, and externally valid instrument with potential for better addressing older adults’ health needs and optimizing risk stratification at the population level.